Literature DB >> 16222146

Chemo-inducible gene therapy.

James J Mezhir1, Hank Schmidt, Bakhtiar Yamini, Neil N Senzer, Mitchell C Posner, Donald W Kufe, Ralph R Weichselbaum.   

Abstract

Chemo-inducible cancer gene therapy is a potential new treatment for solid tumors that may in part enhance the anti-tumor effects of chemotherapy while minimizing toxicity. This approach combines viral vectors expressing cytotoxic transgenes that can be transcriptionally activated by DNA-damaging agents. The development of chemo-inducible gene therapy has numerous implications for the treatment of both localized and metastatic disease in patients with solid tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16222146     DOI: 10.1097/00001813-200511000-00003

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  2 in total

1.  Transcriptional control of Flt3 ligand targeted by fluorouracil-induced Egr-1 promoter in hematopoietic damage.

Authors:  Nan Du; Xuetao Pei; Jinming Zhou; Hui Zhao; Xiaosong Li; Yan Fu; Yixin Hao
Journal:  J Biomed Sci       Date:  2009-09-21       Impact factor: 8.410

2.  Human Germline CRISPR-Cas Modification: Toward a Regulatory Framework.

Authors:  Niklaus H Evitt; Shamik Mascharak; Russ B Altman
Journal:  Am J Bioeth       Date:  2015       Impact factor: 11.229

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.